TickerFactsScreenerDevelopers

HERON THERAPEUTICS, INC. /DE/ (HRTX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2009: -$11.00M2010: -$5.48M2011: -$7.72M2012: -$17.01M2013: -$40.76M2014: -$60.28M2015: -$78.53M2016: -$134.10M2017: -$170.30M2018: -$191.81M2019: -$124.58M2020: -$184.82M2021: -$203.35M2022: -$146.91M2023: -$58.79M2024: -$22.53M2025: -$27.59M-$27.59M
2009Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$27.59M-22.5%
2024-$22.53M+61.7%
2023-$58.79M+60.0%
2022-$146.91M+27.8%
2021-$203.35M-10.0%
2020-$184.82M-48.4%
2019-$124.58M+35.0%
2018-$191.81M-12.6%
2017-$170.30M-27.0%
2016-$134.10M-70.8%
2015-$78.53M-30.3%
2014-$60.28M-47.9%
2013-$40.76M-139.7%
2012-$17.01M-120.3%
2011-$7.72M-40.8%
2010-$5.48M+50.2%
2009-$11.00M—